44.74 USD
NAV Per Share
Exchange Traded Funds (ETF)
Type of fund
Equity
Investment category
Biotech
Sector
USA
Investor locations
06/11/2014
Inception Date
333.24 mln USD
Total assets of the fund
0.4 %
Total Cost Ratio
NASDAQ Biotechnology Index
Benchmark
Invesco
Provider
333.24 mln USD
Stock class assets
No
Dividend payments
-
Replication method
-
Minimum entry threshold
-
Split
IE00BQ70R696
ISIN
SBIO
Ticker
CEOGMS
CFI